Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Theseus Pharmaceuticals Q2 EPS $(0.34) Down From $(0.30) YoY; Cash Position Of $234.2M Is Expected To Provide Cash Runway Into 2026

Author: Benzinga Newsdesk | August 10, 2023 06:07am
Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.34) per share. This is a 13.33 percent decrease over losses of $(0.30) per share from the same period last year.

Posted In: THRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist